IRIS
GARUTI, ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.207
AS - Asia 805
NA - Nord America 587
SA - Sud America 74
AF - Africa 16
OC - Oceania 5
Totale 9.694
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.044
US - Stati Uniti d'America 565
SG - Singapore 304
CN - Cina 209
VN - Vietnam 164
FR - Francia 60
BD - Bangladesh 48
BR - Brasile 44
HK - Hong Kong 28
DE - Germania 25
AR - Argentina 21
FI - Finlandia 14
GB - Regno Unito 13
CA - Canada 11
IQ - Iraq 11
IN - India 10
JP - Giappone 10
NL - Olanda 7
UA - Ucraina 7
CH - Svizzera 6
ES - Italia 6
RU - Federazione Russa 6
EC - Ecuador 5
AU - Australia 4
ID - Indonesia 4
IE - Irlanda 4
MX - Messico 4
SE - Svezia 4
ZA - Sudafrica 4
TR - Turchia 3
UZ - Uzbekistan 3
AL - Albania 2
KE - Kenya 2
MA - Marocco 2
NG - Nigeria 2
PA - Panama 2
PK - Pakistan 2
TN - Tunisia 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CO - Colombia 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
JO - Giordania 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PF - Polinesia Francese 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 9.694
Salva come PNG Salva come JPEG
Città #
Genova 4.762
Genoa 2.020
Rapallo 731
Vado Ligure 479
San Jose 176
Singapore 130
Ashburn 106
Lauterbourg 53
Ho Chi Minh City 47
Beijing 45
Hanoi 28
Hong Kong 27
New York 26
Council Bluffs 25
Frankfurt am Main 23
Los Angeles 19
Santa Clara 17
Helsinki 14
Da Nang 12
Bordighera 11
Haiphong 11
Tokyo 9
Chicago 7
Kyiv 6
Orem 6
Zurich 6
Amsterdam 5
Biên Hòa 5
Phoenix 5
Atlanta 4
Cardiff 4
Charlotte 4
London 4
Milan 4
Naples 4
Paris 4
Stockholm 4
São Paulo 4
Tianjin 4
Baghdad 3
Buenos Aires 3
Buffalo 3
Can Tho 3
Dallas 3
Dublin 3
Johannesburg 3
Madrid 3
Mexico City 3
Rio de Janeiro 3
Rome 3
Sydney 3
Thái Bình 3
Turin 3
Ankara 2
Brooklyn 2
Chennai 2
Denver 2
Des Moines 2
Detroit 2
Dhaka 2
Draper 2
Guayaquil 2
Hải Dương 2
Karbala 2
Miami 2
Montreal 2
Nairobi 2
Nha Trang 2
Panama City 2
Quảng Ngãi 2
Quận Ba 2
Reggio Emilia 2
San Francisco 2
São Carlos 2
Tirana 2
Toronto 2
Tunis 2
Vĩnh Long 2
Vĩnh Tường 2
Washington 2
Abidjan 1
Acalanes Ridge 1
Accra 1
Addis Ababa 1
Agadir 1
Ahmedabad 1
Aktobe 1
Amman 1
Angola 1
Anápolis 1
Aracaju 1
Araraquara 1
Athens 1
Austin 1
Avellaneda 1
Baku 1
Basingstoke 1
Basra 1
Belgrade 1
Belo Horizonte 1
Totale 8.967
Salva come PNG Salva come JPEG
Nome #
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 317
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 249
APO866 activity in hematologic malignancies: a preclinical in vitro study. 247
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 219
Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction. 209
Uncovering the genomic heterogeneity of multifocal breast cancer 205
A new human calpastatin skipped of the inhibitory region protects calpain-1 from inactivation and degradation 203
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 202
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. 202
Ras-induced resistance to lapatinib is overcome by MEK inhibition 200
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma 193
Moderate increase of indoxyl sulfate promotes monocyte transition into profibrotic macrophages 192
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 192
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 192
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes. possible relevance to the assays for the detection of micrometastatic breast cancer 190
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF 189
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 188
Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer 187
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 185
Circulating tumor DNA using tagged targeted deep sequencing to assess minimal residual disease in breast cancer patients undergoing neoadjuvant chemotherapy 183
B-Amyloid 1-42 and RAGE play a key role in ATRA-induced neuronal differentiation 181
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 181
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 177
The increased activity of BACE1 correlates with oxidative stress in Alzheimer’s disease. 176
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. 176
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. 176
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 174
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 173
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 173
Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma 172
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer 172
High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas. 171
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 169
Mutant presenilin 1 increases the expression and activity of BACE1. 167
Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells 167
Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate. 166
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. 162
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 160
Catastrophic NAD+ Depletion through Nampt Inhibition in Activated T Lymphocytes Reduces Demyelination and Disability in EAE. 158
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis 156
Optimization of a wga-free molecular tagging-based ngs protocol for ctcs mutational profiling 152
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease 151
Germline mutations in the von Hippel-Lindau gene in Italian patients. 151
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 150
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib 150
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. 148
Reliability and reproducibility of a RNA preamplification method for low-density array analysis from formalin-fixed paraffin-embedded breast cancer samples. 139
Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia 136
Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer 131
Depletion of the intracellular coenzyme NAD plus in activated T-cells ameliorates experimental autoimmune encephalomyelitis 125
The role of alpha-interferon in chronic myelogenous leukaemia in imatinib era. 122
Mutational analysis of BRCA1 and BRCA2 genes in high grade serous ovarian carcinoma with Next Generation Sequencing (NGS); correlation between somatic and germline mutations 121
Transcriptome Sequencing Of The Transition From Normal Epithelium To Invasive Cancer Reveals Insights Into The Carcinogenesis Of Hpv+ And Hpv- Vulvar Neoplasia 115
Potent Synergistic Activity of the NAD plus Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. 113
β-amyloid 1-42 induces physiological transcriptional regulation of BACE1. 101
SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancer 89
Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer 79
LncRNA EPR regulates intestinal mucus production and protects against inflammation and tumorigenesis 63
Totale 9.787
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.578
article - articoli 28.420
book - libri 0
conference - conferenze 788
curatela - curatele 0
other - altro 370
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.156
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 0 0 35
2021/2022789 28 59 66 110 28 50 52 168 34 63 46 85
2022/2023896 93 98 10 100 147 121 10 64 133 1 112 7
2023/2024487 20 53 4 69 33 98 19 38 19 18 37 79
2024/20251.307 47 85 43 90 151 110 116 278 37 51 137 162
2025/20262.256 297 63 118 159 354 164 344 118 181 238 146 74
Totale 9.787